NPM1::ALK fusion-derived circular RNAs drive aggressiveness in ALK-positive anaplastic large cell lymphoma

Safety, Efficacy, and Pharmacokinetics of Unecritinib (TQ-B3101) in Pediatric Patients With Relapsed/Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma: A Phase I Study.
Suying Lu, Junting Huang, Ruiqing Cai +8
MedComm5 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
A case report: axillary ALK-positive anaplastic large-cell lymphoma mimicking an infectious abscess in an adolescent
Zhanwei Wang, Liuhong Yuan, Xudong Guan +4
Frontiers in oncology2 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCCrossref
Surgical conversion after anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) therapy in N3 stage ALK-positive non-small cell lung cancer: a report of three cases.
Beike Xiao, Hao Guo, Jiatao Zhang +1
Translational lung cancer research30 Sep 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK‐positive anaplastic large‐cell lymphoma
Jietian Jin, Wenjian Cen, Qin Yan +4
Histopathology31 Jul 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
Dirozalkib versus Crizotinib in Advanced Anaplastic Lymphoma Kinase Inhibitor-Naïve ALK-Positive Non-Small-Cell Lung Cancer: A Multicenter, Randomized Phase III Trial.
Ying Liu, Xiangjiao Meng, Yan Yu +15
Cancer communications (London, England)10 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC

Cite

BibTeX

@misc{babin2026npm1alk,
  title = {{NPM1::ALK fusion-derived circular RNAs drive aggressiveness in ALK-positive anaplastic large cell lymphoma}},
  author = {L. BABIN and L. Colras and S. Dailhau and S. Fuchs and S. Pyronnet and L. Lamant and F. Meggetto},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.09.765349},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.09.765349v1},
}

RIS

TY  - UNPB
TI  - NPM1::ALK fusion-derived circular RNAs drive aggressiveness in ALK-positive anaplastic large cell lymphoma
AU  - L. BABIN
AU  - L. Colras
AU  - S. Dailhau
AU  - S. Fuchs
AU  - S. Pyronnet
AU  - L. Lamant
AU  - F. Meggetto
PY  - 2026
DA  - 2026/11/09
PB  - bioRxiv
DO  - 10.64898/2026.11.09.765349
UR  - https://www.biorxiv.org/content/10.64898/2026.11.09.765349v1
ER  -

Related

Cite